We’ve seen Boston Dynamics‘ Spot robot walking, running, dancing, and aperture doors. Now, the aggregation has assigned it a more important task during the coronavirus pandemic: telemedicine.

In this new solution, the iPad army on the robot lets health workers acquaint with patients remotely, saving time, abbreviation exposure, and preserving personal careful accessories (PPE). The newly developed appliance is already under trial in Bringham and Women’s Hospital in Massachusetts. 

Boston Dynamics said it’s open-sourcing this applications’ accouterments and software design used for developers and robot-makers to advance solutions for  angry coronavirus:

We developed the payload, hardware, and software for this appliance so that they are generalizable and able to be deployed on other mobile automatic platforms with APIs and accommodation for custom payloads.

Today, we are administration the after-effects of our antecedent work deploying the robot with Bringham and Women’s Hospital in Massachusetts and we are open-sourcing the accouterments and software designs used to get these robots into the field. Our hope is that these tools can enable developers and roboticists to rapidly deploy robots in order to reduce risks to medical staff.

The firm is also exploring ways to admeasurement body temperature, respiratory rate, pulse rate, and oxygen assimilation accidentally via Spot. It aims to gauge body temperature and respiratory rate through a thermal camera and pulse rate through an externally-mounted RGB camera.


At later stages, the team wants to mount a antibacterial technology such as a UV-C light on the back of Spot to sanitizer patients and surfaces around the robot. This can be used in baggy barrio such as a metro base or a hospital tent.

You can check out design abstracts and the new application’s code here.

Read next: Innovative leaders must convenance ‘radical empathy’ — abnormally in times of abreast

Corona coverage

Read our daily advantage on how the tech industry is responding to the coronavirus and subscribe to our weekly newsletter Coronavirus in Context.